Is CAT a buy, hold, or sell?
CAT carries a valuation grade of Buy. The trailing P/E of 42.6 sits 93% above the Industrials sector median of 22.0x — a premium that demands sustained earnings delivery. Our discounted cash flow model produces an intrinsic range of $497–$980 — implying a -14% margin of safety at the current price of $856.16. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.
With a 9% beat rate on recent quarters, earnings predictability has been mixed. The most recent quarter delivered a 19.3% earnings surprise. Analyst estimate revisions are trending upward.
What are CAT's key risk factors?
With a beta of 1.60, CAT exhibits a highly aggressive risk profile relative to the broad market. The 95th-percentile CVaR of -9.2% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 0.9% of total portfolio loss in the worst 5% of months. Net margins of 13.3% are significantly above the Industrials sector average of 11%, reflecting durable pricing power. Return on equity of 51.3% indicates highly efficient capital allocation. Debt-to-equity of 231% warrants monitoring for leverage risk.
At 0.00, the put/call ratio skews bullish, with call buyers dominating recent flow. Implied volatility of 2.2% is below realized volatility of 42.2%, potentially making options relatively cheap. Insiders have been net sellers to the tune of $164.2M recently. While routine dispositions are common, the magnitude bears watching. Short interest is low at 2.0% of float, suggesting limited bearish conviction.
How does CAT fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — CAT carries a beta of 1.60, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all buyings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
Among closely correlated names, CAT shows the strongest co-movement with HD (0.25), BA (0.21), AMZN (0.20). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios.
True portfolio risk is a function of the full covariance structure across all buyings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The CAT analysis here is a single node in that larger structure.
For the portfolio construction framework underpinning CAT’s position sizing and conviction rating — including IPS guardrails, Black-Litterman allocation, and CVaR constraints — see: Investment Policy Statement Framework →
